Ge-fei Guan

发表

Identification of a Five-Pseudogene Signature for Predicting Survival and Its ceRNA Network in Glioma

Zhe Xiao, Yulin Wang, Xin Liu, 2019, Front. Oncol..

Overexpression of oncostatin M receptor regulates local immune response in glioblastoma

Xiaoyan Xu, Chen Zhu, Ge-fei Guan, 2019, Journal of cellular physiology.

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy

Chen Zhu, Ge-fei Guan, Peng Cheng, 2020, Frontiers in Oncology.

Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioblastoma

Chen Zhu, Ge-fei Guan, Guo-li Wang, 2020, Aging.

ARL3 is downregulated and acts as a prognostic biomarker in glioma

Yulin Wang, Xin Liu, Ge-fei Guan, 2019, Journal of Translational Medicine.

(2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis

Ke Xu, H. Zhong, Ge-fei Guan, 2015, PloS one.

CD48 is a key molecule of immunomodulation affecting prognosis in glioma

Xiaoyan Xu, Chen Zhu, Ge-fei Guan, 2019, OncoTargets and therapy.

Development of A Vitamin-Related Gene Signature to Predict the Immune Characteristics and Prognosis of Glioma

Ge-fei Guan, A. Wu, Wen Cheng, 2020 .

ITGA3 Is a Reliable Biomarker and Putative Therapeutic Target for Glioma

Chen Zhu, Ge-fei Guan, A. Wu, 2020 .

Genome-Wide Profiling and Clinical Significance of Alternative Splicing Events in Glioblastoma

Xiaoyan Xu, Chen Zhu, Ge-fei Guan, 2020 .

Cancer cell intrinsic TIM-3 induces glioblastoma progression

Xiaoyan Xu, Chen Zhu, Ge-fei Guan, 2022, iScience.

Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.

Chen Zhu, Ge-fei Guan, Zhiguo Lin, 2022, Neuro-oncology.

A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients

Yulin Wang, Xin Liu, Ge-fei Guan, 2019, Front. Neurol..

Integrated profiling identifies caveolae‐associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients

Chen Zhu, Ge-fei Guan, Peng Cheng, 2018, CNS neuroscience & therapeutics.

Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma

Ge-fei Guan, Peng Cheng, A. Wu, 2020, Journal of translational medicine.

TGF‐β triggers HBV cccDNA degradation through AID‐dependent deamination

Jianbo Sun, Xiaoxu Han, Ge-fei Guan, 2016, FEBS letters.

ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL

Yang Jiang, Yulin Wang, Ge-fei Guan, 2018, BMC Cancer.

Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma

Xiaoyan Xu, Chen Zhu, Ge-fei Guan, 2019, Oncoimmunology.

A risk signature with four autophagy‐related genes for predicting survival of glioblastoma multiforme

Zhe Xiao, Yulin Wang, Xin Liu, 2020, Journal of cellular and molecular medicine.

Genome profiling of mismatch repair genes in eight types of tumors

Chen Zhu, Ge-fei Guan, A. Wu, 2021, Cell cycle.

AID recruits the RNA exosome to degrade HIV‐1 nascent transcripts through interaction with the Tat‐P‐TEFb‐TAR RNP complex

Haibo Ding, Yuntao Wu, Bin Zhao, 2018, FEBS letters.

Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma

Chen Zhu, Ge-fei Guan, Ling Chen, 2022, Oncoimmunology.

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma

Chen Zhu, Ge-fei Guan, Peng Cheng, 2020, OncoTargets and therapy.

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma

Ge-fei Guan, Peng Cheng, A. Wu, 2019, Front. Oncol..

Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network

Xia Li, Xiaoyan Xu, Ge-fei Guan, 2019, Aging.

LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT

Ge-fei Guan, Peng Cheng, A. Wu, 2020, Frontiers in Oncology.

ARL3 is downregulated and acts as a prognostic biomarker in glioma

Yulin Wang, Xin Liu, Ge-fei Guan, 2019, Journal of Translational Medicine.

Ependymoblastoma with cystic change in a child.

Ge-fei Guan, Zong-ze Guo, B. Qiu, 2014, Journal of neurosurgery. Pediatrics.

Secretory Pathway Kinase FAM20C, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma

Chen Zhu, Ge-fei Guan, Peng Cheng, 2020, OncoTargets and therapy.

Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma

Chen Zhu, Ge-fei Guan, A. Wu, 2018, CNS neuroscience & therapeutics.

Characterization of an endoplasmic reticulum stress‐related signature to evaluate immune features and predict prognosis in glioma

Ge-fei Guan, Peng Cheng, A. Wu, 2021, Journal of cellular and molecular medicine.

Abnormal changes in voltage-gated sodium channels subtypes NaV1.1, NaV1.2, NaV1.3, NaV1.6 and CaM/CaMKII pathway in low-grade astrocytoma

Mingyi Zhao, Dongyi Zhao, Feng Guo, 2018, Neuroscience Letters.

ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL

Yang Jiang, Yulin Wang, Ge-fei Guan, 2018, BMC Cancer.

Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers.

Yang Liu, Peng Cheng, Ge-fei Guan, 2023, Biochimica et biophysica acta. Reviews on cancer.

Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate

Chen Zhu, Ge-fei Guan, Wen Cheng, 2023, Communications biology.